Arcturus Therapeutics Ltd. Deferred Revenue
Arcturus Therapeutics Ltd. had Deferred Revenue of $7.73 million as of 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2019-05-13
- 2019-03-31: Deferred Revenue, Current $7.73M.
- 2018-12-31: Deferred Revenue, Current $6.27M.
- 2018-09-30: Deferred Revenue, Current $8.45M.
- 2018-06-30: Deferred Revenue, Current $11.17M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2019-03-31 | $7.73M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $6.27M 10-Q · filed 2019-05-13 |
| 2018-09-30 | $8.45M 6-K · filed 2018-11-07 |
| 2018-06-30 | $11.17M 6-K · filed 2018-09-28 |
| 2017-12-31 | $6.46M 10-K · filed 2019-03-18 |
| 2016-12-31 | $4.18M 20-F · filed 2018-05-14 |